Bioporto Diagnostic, Inc.
Country not established
- Devices
- 1
What Bioporto Diagnostic, Inc. makes
Bioparto Diagnostic, Inc. manufactures the ProNephro AKI™ test, a diagnostic device for detecting acute kidney injury (AKI) using neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker.
The ProNephro AKI™ test is classified as a Class II medical device and is listed under the FDA’s 510(k) pathway. The company is based in the United States.
Catalogue
ProNephro AKI™ (NGAL) Ref K232761
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Bioporto Diagnostic, Inc. have in the registry?
The registry currently lists 1 device for Bioporto Diagnostic, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Bioporto Diagnostic, Inc.'s devices?
Among its 1 most recently registered device, Bioporto Diagnostic, Inc. has devices listed in FDA 510(k) (1 device).
What risk classes do Bioporto Diagnostic, Inc.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Bioporto Diagnostic, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Bioporto Diagnostic, Inc. in the registry?
The most recently registered devices listed for Bioporto Diagnostic, Inc. include ProNephro AKI™ (NGAL).